SCHEMBL28849066

SCHEMBL28849066

O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 16/20 1.00
ADRA1A P35348 2/20 0.69
DRD4 P21917 2/20 0.69
DRD3 P35462 2/20 0.69
MEN1 O00255 1/20 0.69
CACNA1F O60840 1/20 0.69
KCNK2 O95069 1/20 0.69
ABCB11 O95342 1/20 0.69
CYP1A2 P05177 1/20 0.69
ADRB2 P07550 1/20 0.69
CHRM2 P08172 1/20 0.69
CHRM4 P08173 1/20 0.69
ABCB1 P08183 1/20 0.69
CYP3A4 P08684 1/20 0.69
HTR1A P08908 1/20 0.69
CHRM5 P08912 1/20 0.69
ADRA2A P08913 1/20 0.69
CYP2D6 P10635 1/20 0.69
CHRM1 P11229 1/20 0.69
CYP2C9 P11712 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11841172 0.87 DRD2 (1.00) DRD2ADRA1ADRD4DRD3MEN1
Hydrochloric Acid SCHEMBL11842925 0.86 DRD2 (0.98) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL11847307 0.85 DRD2 (0.81) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL8986115 0.85 DRD2 (0.77) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL11842336 0.84 DRD2 (0.80) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL9050736 0.84 DRD2 (1.00) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL11606132 0.83 DRD2 (0.74) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL11844166 0.83 DRD2 (0.77) DRD2ADRA1ADRD4DRD3MEN1
SCHEMBL11847404 0.83 DRD2 (0.77) DRD2ADRA1ADRD4DRD3MEN1
Chlorohaloperidol SCHEMBL4112719 0.82 DRD2 (1.00) DRD2ADRA1ADRD4DRD3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118125969-A Haloperidol with excellent biological performance and preparation method and application thereof 湖南洞庭药业股份有限公司 2024-06-04 CN disclosed
CN-114099427-B Methods and compositions for treating mental disorders 湖南洞庭药业股份有限公司 2023-11-10 CN disclosed
CN-114099427-A Methods and compositions for treating psychiatric disorders 湖南洞庭药业股份有限公司 2022-03-01 CN disclosed